Загрузка страницы

HSCT: are we ready for prime time? - ECTRIMS 2019

Does HSCT deserve more focus as a first-line treatment? MS Reporter Rob spoke to Dr Joachim Burman at ECTRIMS 2019 to discuss his research into this popular topic. Is HSCT efficacious, is it cost effective - and is it safe?
MS Reporters are people living with Multiple Sclerosis. They're interviewing world leading experts and making sense of the information they provide.

Have you got a question for an Expert?
https://shift.ms/msreporters/got-a-question

Join the Shift.ms community - https://shift.ms/
Watch more videos here: https://shift.ms/msreporters

https://www.facebook.com/shift.ms/
https://twitter.com/shiftms
https://www.instagram.com/shiftdotms/

#MSReporters #multiplesclerosis

Видео HSCT: are we ready for prime time? - ECTRIMS 2019 канала LivedHealth MS
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
13 сентября 2019 г. 13:17:58
00:06:25
Яндекс.Метрика